536 related articles for article (PubMed ID: 29660231)
1. Plakoglobin restores tumor suppressor activity of p53
Alaee M; Nool K; Pasdar M
Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
3. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
4. Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ.
Aktary Z; Kulak S; Mackey J; Jahroudi N; Pasdar M
J Cell Sci; 2013 Jul; 126(Pt 14):3031-42. PubMed ID: 23687381
[TBL] [Abstract][Full Text] [Related]
5. Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis.
Aktary Z; Alaee M; Pasdar M
Oncotarget; 2017 May; 8(19):32270-32291. PubMed ID: 28416759
[TBL] [Abstract][Full Text] [Related]
6. The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion.
Alaee M; Padda A; Mehrabani V; Churchill L; Pasdar M
Oncotarget; 2016 May; 7(18):26898-915. PubMed ID: 27058623
[TBL] [Abstract][Full Text] [Related]
7. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
8. Defining the roles of beta-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using beta-catenin/plakoglobin-null F9 cells.
Shimizu M; Fukunaga Y; Ikenouchi J; Nagafuchi A
Mol Cell Biol; 2008 Jan; 28(2):825-35. PubMed ID: 17984222
[TBL] [Abstract][Full Text] [Related]
9. Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.
Aktary Z; Chapman K; Lam L; Lo A; Ji C; Graham K; Cook L; Li L; Mackey JR; Pasdar M
Oncogene; 2010 Apr; 29(14):2118-29. PubMed ID: 20101217
[TBL] [Abstract][Full Text] [Related]
10. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
11. PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.
Shtutman M; Zhurinsky J; Oren M; Levina E; Ben-Ze'ev A
Cancer Res; 2002 Oct; 62(20):5947-54. PubMed ID: 12384561
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
Dong P; Xu Z; Jia N; Li D; Feng Y
Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
[TBL] [Abstract][Full Text] [Related]
13. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
Alaee M; Danesh G; Pasdar M
PLoS One; 2016; 11(5):e0154323. PubMed ID: 27144941
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC
Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the oncogenic potential of beta-catenin by the subcellular distribution of plakoglobin.
Li L; Chapman K; Hu X; Wong A; Pasdar M
Mol Carcinog; 2007 Oct; 46(10):824-38. PubMed ID: 17415780
[TBL] [Abstract][Full Text] [Related]
16. The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer.
Barta JA; Pauley K; Kossenkov AV; McMahon SB
Carcinogenesis; 2020 Mar; 41(1):67-77. PubMed ID: 31067569
[TBL] [Abstract][Full Text] [Related]
17. Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).
Sechler M; Borowicz S; Van Scoyk M; Avasarala S; Zerayesus S; Edwards MG; Kumar Karuppusamy Rathinam M; Zhao X; Wu PY; Tang K; Bikkavilli RK; Winn RA
J Biol Chem; 2015 Jun; 290(25):15610-15620. PubMed ID: 25925948
[TBL] [Abstract][Full Text] [Related]
18. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
Aktary Z; Pasdar M
PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
[TBL] [Abstract][Full Text] [Related]
19. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.
Kogan-Sakin I; Tabach Y; Buganim Y; Molchadsky A; Solomon H; Madar S; Kamer I; Stambolsky P; Shelly A; Goldfinger N; Valsesia-Wittmann S; Puisieux A; Zundelevich A; Gal-Yam EN; Avivi C; Barshack I; Brait M; Sidransky D; Domany E; Rotter V
Cell Death Differ; 2011 Feb; 18(2):271-81. PubMed ID: 20689556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
